How intestinal bacteria can promote HIV replication

AIDS Reviews

Volumn 15, Issue 1, 2013, Pages 32-37

  Shu, Zhanjun ^a   Ma, Jianping ^a   Tuerhong, Dilinuer ^a   Yang, Chengxin ^b   Upur, Halmurat ^c  

^a National Traditional Chinese Medicine Clinical Research Bases   (China)

^b Infectious Disease Dept   (China)

^c XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

HIV replication; Intestinal bacteria

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BACTERIUM LIPOPOLYSACCHARIDE; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; INTERLEUKIN 10; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; RIBOSOME DNA; TOLL LIKE RECEPTOR 4;

ANTIVIRAL THERAPY; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; COMMENSAL; CYTOKINE PRODUCTION; DENDRITIC CELL; GASTROINTESTINAL TRACT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; INNATE IMMUNITY; INTESTINE FLORA; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC CIRCULATION; VIRUS IMMUNITY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

DENDRITIC CELLS; FEMALE; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION, VIRAL; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-10; MALE; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TOLL-LIKE RECEPTOR 4; VIRUS REPLICATION;

EID: 84883081500     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Savage D. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977;31:107-33.
2. Backhed F, Ley R, Sonnenburg J, Peterson D, Gordon J. Host-bacterial mutualism in the human intestine. Science. 2005;307:1915-20.
3. Shu Z, Cao Y, Halmurat U. Gut flora may offer new therapeutic targets for the traditional Chinese medicine enteric dialysis. Expert Opin Ther Targets. 2011;15:1147-52.
4. Kuss S, Best G, Etheredge C, et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science. 2011;334: 249-52.
5. Pennisi E. Microbiology. Gut bacteria lend a molecular hand to viruses. Science. 2011;334:168.
6. Malim M, Emerman M. HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe. 2008;3:388-98.
7. Dittmer U, He H, Messer R, et al. Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity. 2004;20:293-303.
8. Jude B, Pobezinskaya Y, Bishop J, et al. Subversion of the innate immune system by a retrovirus. Nat Immunol. 2003;4:573-8.
9. Kane M, Case L, Kopaskie K, et al. Successful transmission of a retrovirus depends on the commensal microbiota. Science. 2011;334:245-9.
10. van Wijk F, Cheroutre H. Mucosal T cells in gut homeostasis and inflammation. Expert Rev Clin Immunol. 2010;6:559-66.
11. Macdonald T, Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005;307:1920-5.
12. Mowat A, Viney J. The anatomical basis of intestinal immunity. Immunol Rev. 1997;156:145-66.
13. Moncada D, Kammanadiminti S, Chadee K. Mucin and toll-like receptors in host defense against intestinal parasites. Trends Parasitol. 2003;19:305-11.
14. Shacklett B, Anton P. HIV infection and gut mucosal immune function: updates on pathogenesis with implications for management and intervention. Curr Infect Dis Rep. 2010;12:19-27.
15. Brenchley J, Douek D. HIV infection and the gastrointestinal immune system. Mucosal Immunol. 2008;1:23-30.
16. Lakshmanan V, Alter G, Altfeld M, Bhardwaj N. Biology of plasmacytoid dendritic cells and natural killer cells in HIV-1 infection. Curr Opin HIV AIDS. 2007;2:189-200.
17. Thompson M, Kaminski J, Kurt-Jones E, Fitzgerald K. Pattern recognition receptors and the innate immune response to viral infection. Viruses. 2011;3:920-40.
18. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol. 2006;117:979-87.
19. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34:637-50.
20. Pang I, Iwasaki A. Control of antiviral immunity by pattern recognition and the microbiome. Immunol Rev. 2012;245:209-26.
21. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229-41.
22. Medzhitov R, Preston-Hurlburt P, Janeway C. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997;388:394-7.
23. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282: 2085-8.
24. Samarasinghe R, Tailor P, Tamura T, Kaisho T, Akira S, Ozato K. Induction of an anti-inflammatory cytokine, IL-10, in dendritic cells after toll-like receptor signaling. J Interferon Cytokine Res. 2006;26:893-900.
25. Rassa J, Meyers J, Zhang Y, Kudaravalli R, Ross S. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci USA. 2002;99:2281-6.
26. Sharpstone D, Neild P, Crane R, et al. Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut. 1999;45:70-6.
27. Batman P, Kotler D, Kapembwa M, et al. HIV enteropathy: crypt stem and transit cell hyperproliferation induces villous atrophy in HIV/Microsporidia- infected jejunal mucosa. AIDS. 2007;21:433-9.
28. Brenchley J, Price D, Schacker T, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-71.
29. Gori A, Tincati C, Rizzardini G, et al. Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J Clin Microbiol. 2008; 46:757-8.
30. Douek D, Roederer M, Koup R. Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med. 2009;60:471-84.
31. Sankaran S, George M, Reay E, et al. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol. 2008;82:538-45.
32. Merlini E, Bai F, Bellistri G, Tincati C, d'Arminio Monforte A, Marchetti G. Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy. PLoS One. 2011;6:e18580.
33. Jiang W, Lederman M, Hunt P, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis. 2009; 199:1177-85.
34. Ferri E, Novati S, Casiraghi M, et al. Plasma levels of bacterial DNA in HIV infection: the limits of quantitative polymerase chain reaction. J Infect Dis. 2010;202:176-7.
35. Marchetti G, Cozzi-Lepri A, Merlini E, et al. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. AIDS. 2011;25:1385-94.
36. Brenchley J, Price D, Douek D. HIV disease: fallout from a mucosal catastrophe? Nat Immunol. 2006;7:235-9.
37. Paiardini M, Frank I, Pandrea I, Apetrei C, Silvestri G. Mucosal immune dysfunction in AIDS pathogenesis. AIDS Rev. 2008;10:36-46.
38. Marchetti G, Bellistri G, Borghi E, et al. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS. 2008; 22:2035-8.
39. Cunningham-Rundles S, Ahrne S, Johann-Liang R, et al. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Nutrients. 2011;3:1042-70.